1 study on Lcklsl curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study identifies LCKLSL as a promising novel therapeutic candidate for the treatment of retinal neovascularization. By specifically targeting ANXA2, a key regulator of cell proliferation and angiogenesis (the for…